​

Kronos Bio Ownership | Who Owns Kronos Bio?

OverviewForecastRevenueFinancialsChart

Kronos Bio Ownership Summary

Kronos Bio is owned by 31.46% institutional investors, 24.31% insiders, and 44.23% retail investors. Vanguard group is the largest institutional shareholder, holding 3.19% of KRON shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in Kronos Bio shares.

KRON Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKronos Bio31.46%24.31%44.23%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryBiotech Stocks 63.94%10.67%25.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.92M3.19%$1.83M
Millennium management1.72M2.85%$1.63M
Alphabet1.44M2.38%$1.37M
Acadian asset management1.30M2.16%$1.24M
Renaissance1.17M1.94%$1.11M
Tang capital management1.00M1.66%$953.21K
Blackrock874.10K1.47%$1.08M
Artal group842.95K1.42%$1.05M
Siren842.95K1.40%$800.81K
Blackrock funding, inc. /de774.28K1.28%$735.56K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alphabet1.44M0.08%$1.37M
Tang capital management1.00M0.06%$953.21K
Siren842.95K0.04%$800.81K
Velan capital investment management lp35.00K0.03%$33.25K
Artal group842.95K0.03%$1.05M
Partners capital investment group, llp527.50K0.01%$501.13K
Gentrust295.25K0.01%$280.48K
Samsara biocapital78.13K0.01%$74.22K
Casdin capital123.84K0.01%$117.65K
Bluefin capital management25.10K0.01%$31.12K

Top Buyers

HolderShares% AssetsChange
Tang capital management1.00M0.06%1.00M
Jacobs levy equity management440.74K0.00%381.34K
Renaissance1.17M0.00%192.75K
Squarepoint ops98.42K0.00%98.42K
Susquehanna group, llp121.87K-71.62K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---2.91M
Vida ventures advisors---2.77M
Wildcat capital management---1.30M
Partners capital investment group, llp527.50K0.01%-1.08M
Mariner---1.04M

New Positions

HolderShares% AssetsChangeValue
Tang capital management1.00M0.06%1.00M$953.21K
Squarepoint ops98.42K0.00%98.42K$93.50K
Velan capital investment management lp35.00K0.03%35.00K$33.25K
Bnp paribas arbitrage, snc471.00-471.00$447.00

Sold Out

HolderChange
Qube research-297.00
Wells fargo & company/mn-347.00
Citigroup-724.00
Advisor group-1.66K
Ubs group-2.01K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202548-17.24%19,132,784-2.63%312.96%13-43.48%1550.00%
Dec 31, 202428-48.15%14,008,974-28.90%232.18%9-50.00%6-60.00%
Sep 30, 202453-5.36%19,689,996-4.63%322.71%17-19.05%157.14%
Jun 30, 202456-3.45%20,645,660-4.86%342.46%215.00%14-12.50%
Mar 31, 202458-1.69%21,700,397-18.86%371.78%2011.11%16-5.88%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.32M2.16%-
Vanguard Total Stock Mkt Idx Inv1.32M2.16%-
Vanguard Institutional Extnd Mkt Idx Tr559.54K0.92%-
Fidelity Extended Market Index234.08K0.38%-1.05K
Kennedy Micro Cap Opportunities148.07K0.25%11.66K
Bridgeway Ultra-Small Company Market118.93K0.20%-
iShares Micro-Cap ETF91.52K0.15%-
Forefront Tiresias Strategy86.58K0.14%2.19K
Bridgeway Ultra-Small Company77.47K0.13%-115.30K
Fidelity Total Market Index76.18K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 05, 2025KNOBELMAN DEBORAH President & Interim CEOSell$21.55K
Jun 27, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$478.84K
Jun 28, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$254.96K
Jun 11, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$814.57K
Jun 12, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$1.10M

Insider Transactions Trends

DateBuySell
2025 Q2-1
2024 Q4--
2024 Q25-
2024 Q1-6
2023 Q432

KRON Ownership FAQ

Who Owns Kronos Bio?

Kronos Bio shareholders are primarily institutional investors at 31.46%, followed by 24.31% insiders and 44.23% retail investors. The average institutional ownership in Kronos Bio's industry, Biotech Stocks , is 63.94%, which Kronos Bio falls below.

Who owns the most shares of Kronos Bio?

Kronos Bio’s largest shareholders are Vanguard group (1.92M shares, 3.19%), Millennium management (1.72M shares, 2.85%), and Alphabet (1.44M shares, 2.38%). Together, they hold 8.42% of Kronos Bio’s total shares outstanding.

Does Blackrock own Kronos Bio?

Yes, BlackRock owns 1.47% of Kronos Bio, totaling 874.1K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.08M$. In the last quarter, BlackRock decreased its holdings by -35.348K shares, a -3.89% change.

Who is Kronos Bio’s biggest shareholder by percentage of total assets invested?

Alphabet is Kronos Bio’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 1.44M Kronos Bio shares, valued at 1.37M$.

Who is the top mutual fund holder of Kronos Bio shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Kronos Bio shares, with 2.16% of its total shares outstanding invested in 1.32M Kronos Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools